NSECertificate under SEBI (Depositories and Participants) Regulations, 20187 Oct 2026 · 7 Oct 2026, 07:04 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Strides Pharma Science Limited · STAR

✦ AI Summary

Strides Pharma Science Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Strides Pharma Science Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026

Attachments (1)

📄

STRIDES_07102026185728_SE_Intimation.pdf

pdf

Download →
View document text
October 7, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400 051. Dalal Street, Mumbai – 400 001. Scrip Code: STAR Scrip Code: 532531 Dear Sir/ Madam, Sub: Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. In compliance with regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we hereby enclose a copy of the certificates received from KFin Technologies Limited, the Registrar and Share Transfer Agent of Strides Pharma Science Limited (the “Company”), for the quarter ended September 30, 2026. Kindly take the same on record. Thanks & Regards, For Strides Pharma Science Limited, Manjula Ramamurthy Company Secretary & Compliance Officer ICSI Membership No. A30515 Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000 Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India | Tel: +91 22 2789 2924/3199 corpcomm@strides.com; www.strides.com KFIN/STR/NSDL/74(5) E/1 Date: 02‐10‐2026 NATIONAL SECURITIES DEPOSITORY LIMITED TRADE WORLD 4TH FLOOR KAMALA MILLS COMPOUND SENAPATI BAPAT MARG LOWER PAREL MUMBAI ‐ 400 013 Dear Sir(s), Sub: Certificate under Regulation 74(5) for the quarter ended September 30,2026 We as Registrar to an Issue and Share Transfer Agent of the STRIDES PHARMA SCIENCE LIMITED, certify that the details of securities dematerialized/rematerialized during the aforesaid period, as required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been furnished to all the Stock Exchanges where the shares of the company are listed. Thanking You Yours faithfully, for KFIN TECHNOLOGIES LIMITED VAGOLU RATNA BABU ASSISTANT VICE PRESIDENT CC TO: STRIDES PHARMA SCIENCE LIMITED CYBER ONE, UNIT NO. 902 PLOT NO. 4 & 6 SECTOR 30A, VASHI NAVI MUMBAI 400703 KFIN/STR/CDSL/74(5) E/1 Date: 02‐10‐2026 CENTRAL DEPOSITORY SERVICES (INDIA) LIMITED REGD OFF: MARATHON FUTUREX, A WING 25TH FLOOR NM JOSHI MARG LOWER PAREL (EAST) MUMBAI ‐ 400 023 Dear Sir(s), Sub: Certificate under Regulation 74(5) for the quarter ended September 30,2026 We as Registrar to an Issue and Share Transfer Agent of the STRIDES PHARMA SCIENCE LIMITED, certify that the details of securities dematerialized/rematerialized during the aforesaid period, as required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been furnished to all the Stock Exchanges where the shares of the company are listed. Thanking You Yours faithfully, for KFIN TECHNOLOGIES LIMITED VAGOLU RATNA BABU ASSISTANT VICE PRESIDENT CC TO: STRIDES PHARMA SCIENCE LIMITED CYBER ONE, UNIT NO. 902 PLOT NO. 4 & 6 SECTOR 30A, VASHI NAVI MUMBAI 400703